Mr. Shaun Flanagan:

In terms of answering that, I am not sure what the Deputy expects. It did not come through a reimbursement process. A standard reimbursement process involves, at the start, the EMA reviewing a medicine for a particular use to decide if the quality, safety and efficacy is appropriate to support market authorisation. After that, we have an assessment process regarding cost-----